Bruton's tyrosine kinase inhibitors: first and second generation agents for patients with Chronic Lymphocytic Leukemia (CLL).
about
Bruton's tyrosine kinase inhibitors: first and second generation agents for patients with Chronic Lymphocytic Leukemia (CLL).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Bruton's tyrosine kinase inhib ...... ic Lymphocytic Leukemia (CLL).
@en
Bruton's tyrosine kinase inhib ...... h Chronic Lymphocytic Leukemia
@nl
type
label
Bruton's tyrosine kinase inhib ...... ic Lymphocytic Leukemia (CLL).
@en
Bruton's tyrosine kinase inhib ...... h Chronic Lymphocytic Leukemia
@nl
prefLabel
Bruton's tyrosine kinase inhib ...... ic Lymphocytic Leukemia (CLL).
@en
Bruton's tyrosine kinase inhib ...... h Chronic Lymphocytic Leukemia
@nl
P2860
P1476
Bruton's tyrosine kinase inhib ...... ic Lymphocytic Leukemia (CLL).
@en
P2093
Jan A Burger
Philip A Thompson
P2860
P356
10.1080/13543784.2018.1404027
P407
P577
2017-11-10T00:00:00Z